-R Nayak Researcher Activity Profile

Research Author Detailed Information 

R Nayak Publication Rate By Year

R Nayak has published 1 paper(s) in 2002, 1 paper(s) in 2006, 12 paper(s) in 2007, 2 paper(s) in 2008, for a total of 16 research publications in total.

R R Nayak Author Information

LAST NAME: nayak

FIRST NAME: R

INITIALS: r

AFFILIATION:

Papers

R Nayak's Publication Record

1. Tubedown-1 in remodeling of the developing vitreal vasculature in vivo and regulation of capillary outgrowth in vitro. Year Published: 2002
Division of Basic Medical Sciences, Department of Medicine, Memorial University of Newfoundland, St. John's NF, A1B 3V6, Canada.
2. Monolithic media in microfluidic devices for proteomics. Year Published: 2006
Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.
3. Positive and negative effects of adenovirus type 5 helper functions on adeno-associated virus type 5 (AAV5) protein accumulation govern AAV5 virus production. Year Published: 2007
Department of Molecular Microbiology and Immunology, University of Missouri-Columbia, 1201 E. Rollins Road, Columbia, MO 65211-7310, USA.
4. Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential. Year Published: 2007
Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, India.
5. Effects of thin-film structural parameters on laser desorption/ionization from porous alumina. Year Published: 2007
Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173 Ashley Avenue, Charleston, South Carolina 29425, USA.
6. Comparison of Salmonella enterica serovar Heidelberg Susceptibility Testing Results. Year Published: 2007
Marshfield Clinic Research Foundation 1000 North Oak Avenue Marshfield, WI 54449 . foley.steven@mcrf.mfldclin.edu.
7. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant. Year Published: 2007
Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, India.
8. Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential. Year Published: 2007
Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, India.
9. Adeno-associated viruses can induce phosphorylation of eIF2alpha via PKR activation, which can be overcome by helper adenovirus type 5 virus-associated RNA. Year Published: 2007
Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri-Columbia, 1201 Rollins Road, Columbia, MO 65211, USA.
10. Perpetuation of immunological memory through common MHC-I binding modes of peptidomimic and antigenic peptides. Year Published: 2007
Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.
11. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant. Year Published: 2007
Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, India.
12. Cephalic tetanus with left infranuclear facial palsy. Year Published: 2008
Department of Medicine, Gandhi Medical College and Hamidia Hospital, Bhopal (M.P.).
13. Comparison of Salmonella enterica serovar Heidelberg susceptibility testing results. Year Published: 2007
National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, Arkansas, USA.
14. Perpetuation of immunological memory through common MHC-I binding modes of peptidomimic and antigenic peptides. Year Published: 2007
Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.
15. Cephalic tetanus with left infranuclear facial palsy. Year Published: 2008
Department of Medicine, Gandhi Medical College and Hamidia Hospital, Bhopal (M.P.).
16. Comparison of Salmonella enterica serovar Heidelberg susceptibility testing results. Year Published: 2007
National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, Arkansas, USA.